Calprotectin Testing Market Overview
The Calprotectin Testing Market was valued at $600 million in 2024 and is projected to reach $1.5 billion by 2035, growing at a CAGR of 8.6%. Calprotectin testing measures the level of a calcium-binding protein in stool, blood, or urine samples to detect intestinal inflammation. It serves as a non-invasive biomarker for diagnosing and monitoring inflammatory bowel diseases (IBD) such as Crohn's...
0 Commentaires 0 Parts 70 Vue 0 Aperçu